(Q36757464)

English

Doxorubicin cardiomyopathy via TLR-2 stimulation: potential for prevention using current anti-retroviral inhibitors such as ritonavir and nelfinavir

scientific article published on June 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

1 reference

Europe PubMed Central

Doxorubicin cardiomyopathy via TLR-2 stimulation: potential for prevention using current anti-retroviral inhibitors such as ritonavir and nelfinavir (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

toll-like receptor

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Kast RE

1

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

Foley KF

2

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

Focosi D

3

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

publication date

1 June 2007

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

Hematological Oncology

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

25

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

96-97

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

Differential cytokine response in host defence mechanisms triggered by gram-negative and gram-positive bacteria, and the roles of gabexate mesilate, a synthetic protease inhibitor

1 reference

https://api.crossref.org/works/10.1002%2FHON.811

21 January 2018

Doxorubicin-induced cardiac mitochondrionopathy

1 reference

https://api.crossref.org/works/10.1002%2FHON.811

7 January 2021

based on heuristic

inferred from DOI database lookup

Serial assessment of doxorubicin cardiotoxicity with quantitative radionuclide angiocardiography

1 reference

https://api.crossref.org/works/10.1002%2FHON.811

7 January 2021

based on heuristic

inferred from DOI database lookup

A clinicopathologic analysis of adriamycin cardiotoxicity

1 reference

https://api.crossref.org/works/10.1002%2FHON.811

7 January 2021

based on heuristic

inferred from DOI database lookup

DNA damage is an early event in doxorubicin-induced cardiac myocyte death

1 reference

https://api.crossref.org/works/10.1002%2FHON.811

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunobiology of Toll-like receptors: emerging trends

1 reference

https://api.crossref.org/works/10.1002%2FHON.811

7 January 2021

based on heuristic

inferred from DOI database lookup

Targeted anticytokine therapy and the failing heart

1 reference

https://api.crossref.org/works/10.1002%2FHON.811

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of innate immune responses in the heart in health and disease

1 reference

https://api.crossref.org/works/10.1002%2FHON.811

7 January 2021

based on heuristic

inferred from DOI database lookup

In Vivo Expression of Proinflammatory Mediators in the Adult Heart after Endotoxin Administration: The Role of Toll‐Like Receptor–4

1 reference

https://api.crossref.org/works/10.1002%2FHON.811

7 January 2021

based on heuristic

inferred from DOI database lookup

Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium

1 reference

https://api.crossref.org/works/10.1002%2FHON.811

7 January 2021

based on heuristic

inferred from DOI database lookup

TLR4-mediated inflammatory activation of human coronary artery endothelial cells by LPS.

1 reference

https://api.crossref.org/works/10.1002%2FHON.811

7 January 2021

based on heuristic

inferred from DOI database lookup

Toll-like receptor-2 modulates ventricular remodeling after myocardial infarction.

1 reference

https://api.crossref.org/works/10.1002%2FHON.811

7 January 2021

based on heuristic

inferred from DOI database lookup

Toll-like receptor 2 modulates left ventricular function following ischemia-reperfusion injury

1 reference

https://api.crossref.org/works/10.1002%2FHON.811

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of TLR-2 in the activation of nuclear factor kappaB by oxidative stress in cardiac myocytes

1 reference

https://api.crossref.org/works/10.1002%2FHON.811

7 January 2021

based on heuristic

inferred from DOI database lookup

Human immunodeficiency virus type 1 protease inhibitors block toll-like receptor 2 (TLR2)- and TLR4-Induced NF-kappaB activation

1 reference

https://api.crossref.org/works/10.1002%2FHON.811

7 January 2021

based on heuristic

inferred from DOI database lookup

The serine protease inhibitor antithrombin III inhibits LPS-mediated NF-kappaB activation by TLR-4.

1 reference

https://api.crossref.org/works/10.1002%2FHON.811

7 January 2021

based on heuristic

inferred from DOI database lookup

Proteasome inhibitor bortezomib modulates TLR4-induced dendritic cell activation

1 reference

https://api.crossref.org/works/10.1002%2FHON.811

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HON.811

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36757464&oldid=1655376453"